This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 7 - 13 February 2026 and includes updates on respiratory virus epidemiology in the EU/EEA, mass gathering monitoring, avian influenza, and mpox.
Respiratory virus activity remains elevated across the EU/EEA: influenza transmission is still widespread but decreasing, and RSV levels remain high, while SARS CoV 2 circulation remains low.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 7 - 13 February 2026 and includes updates on respiratory virus epidemiology in the EU/EEA, mass gathering monitoring, avian influenza, chikungunya, dengue, Nipah virus disease, and measles.
Respiratory virus circulation is elevated across the EU/EEA: the circulation of influenza viruses is still high and RSV circulation is elevated and increasing. SARS-CoV-2 circulation continues to be low.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 31 January - 6 February 2026 and includes updates on respiratory virus epidemiology in the EU/EEA, SARS-CoV-2 variant classification, Bacillus cereus toxin in infant formula, mass gathering monitoring, mpox, nipah virus, and Middle East respiratory virus syndrome.
Respiratory virus circulation is elevated across the EU/EEA. The circulation of influenza viruses remains high with early signs of a new increase, RSV circulation is elevated and increasing, and SARS-CoV-2 circulation remains at low levels.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 24-30 January 2026 and includes updates on respiratory virus epidemiology in the EU/EEA, Marburg virus disease, cholera, avian influenza, bacillus in infant formula, and nipah virus disease.
Respiratory virus circulation is elevated across the EU/EEA: the circulation of influenza viruses remains high with early signs of a new increase, RSV circulation is elevated and increasing, and SARS-CoV-2 circulation remains at low levels.
This e-learning course aims at increasing understanding of the drivers and barriers of vaccine acceptance. You will learn how to design targeted strategies to increase vaccine uptake through behaviour change.